Luca Benatti
CIK 1613842 · last filed 2025-12-29
Luca Benatti is a corporate insider who has filed 18 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider sold $173.5K of QNCX on Dec 29, 2025. Across all open-market trades the lifetime net is +$38.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $36.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$36.6K
2
18
$38.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QNCX | Director | 39,179 | $0.93 | $36.6K | -$173.5K | 5 | 2025-12-29 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 33,598 | $19.00 | $638.4K | $212.1K | 12 | 2023-05-25 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-29 | QNCX | Sell (S) | −50,000 | -$173.5K | EDGAR |
| 2025-12-29 | QNCX | Other (J) | +8,918 | $0 | EDGAR |
| 2025-06-06 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2023-11-13 | — | Mixed | −33,598 | -$638.4K | |
| 2023-10-24 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +8,111 | $0 | EDGAR |
| 2022-05-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +7,737 | $0 | EDGAR |
| 2021-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +7,029 | $0 | EDGAR |
| 2020-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,595 | $0 | EDGAR |